The Effect of the Combination of Two Postbiotics on Anxiety-like Behavior in Animal Models
- PMID: 39682754
- PMCID: PMC11640140
- DOI: 10.3390/cells13232006
The Effect of the Combination of Two Postbiotics on Anxiety-like Behavior in Animal Models
Abstract
With increasing evidence showing the connections between the microbiome, neurophysiology, and behavior, our research endeavors to investigate whether the consumption of a combination of two postbiotics with antioxidant effects can affect behavior regulation in model species. Here, we worked with a combination (1:1 ratio) of heat-treated Bifidobacterium longum subsp. longum ES1 (CECT7347) and Lacticaseibacillus rhamnosus BPL15 (CECT8361) as a dietary supplement. To examine the potential benefit of using this formulation to alleviate anxiety-like behavior, we employed two model species, Caenorhabditis elegans and adult Danio rerio. In C. elegans, the postbiotic supplementation reduced the anxiety-related behavior analyzed by means of the octanol avoidance test. In zebrafish, the novel tank test indicated a different swimming pattern 2 and 4 months after the animals were fed with the postbiotic combination. While fish did not exhibit any variance in their locomotion parameters such as pace and speed, they showed a statistically significant preference to spend more time in the upper zone of the water tank, a behavior that is correlated with a lower anxiety-like behavior in these species. Our aim with this study is to present evidence that can be used to develop whole-cell postbiotic-based novel and innovative dietary supplements for anxiety-related conditions.
Keywords: Bifidobacterium; Lacticaseibacillus; anxiety-like; postbiotics.
Conflict of interest statement
Five authors are from Archer Daniels Midland, Nutrition, Health&Wellness, Biopolis. S.L. and provided the postbiotic and data involved in
Figures
References
-
- VizHub—GBD Results. [(accessed on 23 October 2024)]. Available online: https://vizhub.healthdata.org/gbd-results/
-
- Mental Health and COVID-19: Early Evidence of the Pandemic’s Impact: Scientific Brief. [(accessed on 4 January 2024)]. Available online: https://www.who.int/publications/i/item/WHO-2019-nCoV-Sci_Brief-Mental_h....
-
- Baldwin D.S., Anderson I.M., Nutt D.J., Bandelow B., Bond A., Davidson J.R.T., Den Boer J.A., Fineberg N.A., Knapp M., Scott J., et al. Evidence-Based Guidelines for the Pharmacological Treatment of Anxiety Disorders: Recommendations from the British Association for Psychopharmacology. J. Psychopharmacol. 2016;19:567–596. doi: 10.1177/0269881105059253. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
